ribavirin has been researched along with Fatty Liver, Nonalcoholic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calvisi, DF; Feo, CF; Feo, F; Pascale, RM; Simile, MM | 1 |
| Clément, AC; Cooper, CL; Crawley, AM; Doyle, MA; Fadzeyeva, E; Fullerton, MD; Hanson, AA; Jacobs, RL; Jeraj, N; Kim, KH; Locatelli, CA; Lorenzen-Schmidt, I; Morrow, NM; Mulvihill, EE; Nguyen, MA; Nunes, JR; O'Dwyer, C; Pulente, SM; Seymour, R; Travis, N; Trzaskalski, NA; van der Veen, JN; Vulesevic, B | 1 |
| Chang, SC; Chung, YC; Hung, CT; Lee, HM; Li, SF; Pai, LW; Yang, SS | 1 |
| Callanan, M; Fugier, E; Hoang, XS; Jouvin-Marche, E; Leroy, V; Macek Jílková, Z; Marche, H; Marche, PN; Marlu, A; Sturm, N; Thelu, MA; Van Campenhout, N; Zarski, JP | 1 |
| Kumakawa, M; Matsumoto, N; Matsumura, H; Matsuoka, S; Moriyama, M; Nakamura, H; Nirei, K; Yamagami, H | 1 |
1 review(s) available for ribavirin and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent.
Topics: Animals; Antiviral Agents; Betaine; Carcinogenesis; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Colorectal Neoplasms; Humans; Liver Neoplasms; Male; Methionine Adenosyltransferase; Non-alcoholic Fatty Liver Disease; Rats; Ribavirin; S-Adenosylmethionine | 2022 |
4 other study(ies) available for ribavirin and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Hepatocyte-derived DPP4 regulates portal GLP-1 bioactivity, modulates glucose production, and when absent influences NAFLD progression.
Topics: Animals; Dipeptidyl Peptidase 4; Endothelial Cells; Glucagon-Like Peptide 1; Glucose; Hepatitis C; Hepatocytes; Mice; Non-alcoholic Fatty Liver Disease; Ribavirin | 2023 |
Risk of nonpsychotic mental disorders development in antiviral-treated mentally healthy chronic hepatitis C patients: A population-based study.
Topics: Adult; Antiviral Agents; Chi-Square Distribution; Databases, Factual; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Mental Disorders; Middle Aged; National Health Programs; Non-alcoholic Fatty Liver Disease; Psychiatric Status Rating Scales; Ribavirin; Risk Factors; Taiwan | 2015 |
Lymphocytes degranulation in liver in hepatitis C virus carriers is associated with IFNL4 polymorphisms and ALT levels.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Cell Degranulation; Fatty Liver; Female; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Interleukins; Liver; Lymphocytes; Lysosomal-Associated Membrane Protein 1; Male; Middle Aged; Multivariate Analysis; Natural Killer T-Cells; Non-alcoholic Fatty Liver Disease; Polymorphism, Genetic; Ribavirin; RNA, Viral; Viral Load | 2014 |
Steatosis influences the clinical profiles and long-term outcomes of interferon-treated chronic hepatitis C and liver cirrhosis patients.
Topics: Adult; Antiviral Agents; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Non-alcoholic Fatty Liver Disease; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2017 |